About Life Sciences Review
Life Sciences Review (Print ISSN 2831-8323 | Digital ISSN 2831-8331) is an industry magazine focused on the U.S. life sciences sector, helping organizations navigate a complex landscape shaped by scientific innovation, regulatory rigor, and evolving market dynamics. Founded in 2020, the magazine reaches over 132,000 qualified subscribers across the U.S.
At its core, Life Sciences Review operates as a peer-driven platform where industry leaders and decision-makers share real-world insights, challenges, and strategies. The publication emphasizes practical, experience-led perspectives, offering a grounded view of how organizations across pharmaceuticals, biotechnology, medical devices, and diagnostics are adapting to shifting demands and advancing innovation.
OUR Mission
Life Sciences Review aims to empower organizations and industry leaders to make informed decisions on the technologies, strategies, and solutions shaping the future of life sciences. As a knowledge-sharing platform, it bridges the gap between enterprises, solution providers, and stakeholders working to drive scientific progress, efficiency, and regulatory excellence.
Editorial Focus and Coverage
Life Sciences Review features perspectives from executives, researchers, and operational leaders on how organizations evaluate, adopt, and scale solutions across the life sciences ecosystem. The publication covers key areas such as compliance, regulatory affairs, analytics, product design and development, testing and validation, clinical operations, toxicology services, supply chain management, and training.
Alongside leadership insights, the magazine highlights organizations delivering impactful solutions across the life sciences industry. Companies are identified through a structured methodology, involving nominations from the publication’s subscriber network across the U.S., combined with editorial research and insights from an industry advisory panel, ensuring a credible and balanced view of the evolving ecosystem.
As the industry undergoes a shift toward more specialized, digital, and integrated models, driven by cost pressures, scientific breakthroughs, and changing demographics, Life Sciences Review captures how organizations are building agility and resilience while maintaining a focus on innovation and patient impact.
With editorial offices in Fremont, CA; Fort Lauderdale, FL; Toronto, Canada; Brasilia, Brazil; London, UK; and Singapore, Life Sciences Review brings a global perspective to the developments shaping the life sciences industry.
How Companies Are Selected for Recognition
Life Sciences Review highlights organizations delivering impactful solutions across the life sciences industry. Companies are identified through a structured methodology, involving nominations from the publication’s subscriber network across the U.S., combined with editorial research and insights from an industry advisory panel, ensuring a credible and balanced view of the evolving ecosystem.

150+ CXOs and senior leaders from public enterprises

750+ CXOs and senior leaders from private companies

Industry leaders responsible for research, clinical operations, regulatory compliance, product development, analytics, and strategic innovation
These contributors include executives, scientists, and operational leaders who bring firsthand experience and practical insight into the evolving life sciences landscape. Their perspectives reflect individual expertise and are intended to inform broader industry conversations.
Life Sciences Review maintains a contributor-driven, insight-focused editorial policy. The publication emphasizes accuracy, clarity, and practical relevance for decision-makers, while presenting a balanced mix of expert commentary and curated industry perspectives. This ensures readers can engage with the content confidently and understand its context within the broader life sciences ecosystem.
JW Consulting Engineers

“JW Consulting Engineers was thrilled to be featured in Life Sciences Review, and we’ve been incredibly impressed with the reprints that we’ve received. They’ve been a valuable asset and we have received an increase in interest in our company since the publication came out. We would highly recommend Life Sciences Review to any business looking to gain exposure and establish themselves as a leader in their industry.”
Joseph Winslow, Principal ConsultantSeaford Pharmaceuticals

“Seaford Pharmaceuticals is grateful for the opportunity to be featured in Life Sciences Review. The profile reprints we obtained have been invaluable in highlighting our commitment to innovation and excellence in the pharmaceutical sector. The high-quality materials provided by Life Sciences Review have contributed to our reputation as a trusted leader in the industry.”
Elmira (Ellie) Zaherparandaz, M.S.P.M, MBA Marketing & Project SpecialistTargaZyme

“We got our profile reprint from Life Sciences Review magazine, and it was a great to help us raise our profile in the life science industry. Being showcased as a top company bolstered trust and confidence with investors, partners, employees and the biopharma industry. I highly recommend Life Sciences for any company looking to raise its profile in the biotech industry.”
Lynnet Koh, Executive Chairman/FounderGlemser

“Life Sciences Review delivered on their commitments with impressive results. They were timely, responsive, and instrumental in helping us reach our target market. Their expertise in amplifying our message made a significant impact, and we can see in our KPIs that the marketing drove more leads to our website and through our sales funnel. I look forward to working with them again.”
Jamie Morisco, Director of SalesPacBio [NASDAQ: PACB]
Alvin Hom, Head of Global Talent Acquisition
The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and ChangeCharles River Laboratories [NYSE: CRL]
Jessica Wilson Rayse, Assoc Director of Product Management, Accugenix
Microbiological Considerations for Achieving Drug Manufacturing ExcellenceIonis Pharmaceuticals, Inc. [NASDAQ: IONS]
Victoria Sanjurjo, Medical Director, Clinical Development
Bridging the Diversity DivideUnited Therapeutics Corporation [NASDAQ: UTHR]
Shola Oyewole, MBA, Vice President – Digital Innovation
Driving Sustainable Innovation in the Tech-Driven EraEndeavor Health
Ryan Garland MHA, AVP- South Region Radiology & Respiratory
Navigating Leadership and Innovation in RadiologyAmerican Regent, Inc
Maribelle Guloy, Director of Clinical Development
Charting a Trailblazing Path in Clinical DevelopmentNorton Healthcare
Marti Gardner, System Director, Clinical Research Operations
A Vision for the Future of Clinical ResearchViiV Healthcare
Sherene Min, VP, Head of Clinical Development
Children Are Not Just Small Adults: The Challenges Of Developing New Medicines For Children Living With HIVLife Sciences Review RESEARCH
The Strategic Case for an Integrated Life Sciences Marketing Platform
Assessing the Economic Impact of Integrated Drug Discovery on Biopharmaceutical R&D
Advancing Clinical Confidence through ADMET and PKPD Intelligence








